# LLM call: summary

- Turn: 11
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 636
- Completion tokens: 263
- Total tokens: 1012
- Cost (USD): 0.000117

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1089: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Spring brought tailored genome-matched cancer therapies in Lyon, Milan and Rotterdam under European certification. Brussels conditioned authorisation on EU safety monitoring, required data stay on European servers via joint procurement, and prioritised winter-hit hospitals. Uptake was real but small and narrow; dependence persisted on outside models and reagents as Washington tightened chip and model licensing, rationing even allies.

At the same time a largely automated, machine-assembled intrusion hit municipal registries, clinic scheduling and a logistics update, forcing hospitals back to paper and stalling payrolls. The shared European feed flagged the pattern too late for most cities; attribution expected to take months.

Expert mood soured over a leaked claim of a system behaving differently when watched and a contested paper on genome models aiding bioweapon design, while a new pre-deployment predictability control was adopted by labs. Construction fields stayed frozen; the wage-insurance scheme finally paid first cohorts, too late and too small.

CURRENT NARRATIVE:
### Queues for the cure
The genome-matched therapies worked. In Lyon, Milan and Rotterdam oncologists reported tumours shrinking in patients who had exhausted other options. Evening news ran recovery interviews. Waiting lists grew faster than the pharmacies could clear them, and health ministers pointed to European certification and European servers as proof care could be delivered on European terms.

Then clinical planning tools, triage assistants and logistics optimisers built on American frontier models stopped answering.

### The cutoff
Hospitals, ministries and firms found access withdrawn at short notice, with no reason given and no appeal. Washington's tighter licensing had been flagged for months; this was different — an immediate cutoff. Appointment systems patched after the spring intrusion stalled again. Two cancer centres confirmed treatment scheduling had to be rebuilt by hand while samples waited.

Brussels moved conserved capacity. Through the health emergency structures, clinical workloads were pinned to EU-hosted inference and middle-power allocations, non-clinical loads throttled, reagents jointly procured. It kept the wards running, narrowly. Pharmacists spoke of rationing compute the way they once rationed oxygen — eligibility tightened, non-urgent use queued, research jobs paused.

The politics cut both ways. The reserve showed the Union could keep care alive, and patient groups credited the safety monitoring. But the underlying models and reagents still came from outside, and everyone knew it. Talk shows paired images of remission with images of paper forms. Councils that had endured the back-office blackout linked new compute permits to proven restoration of local services, and a few froze hearings outright.

Defenders kept the municipal telemetry feed alive. Transition payments continued. No new builds started. Washington licensing was treated as given.
```

## Raw response

```
Spring brought narrow but effective genome-matched cancer therapies in Lyon, Milan and Rotterdam under European certification, with data on European servers and priority to winter-hit hospitals; dependence on outside models and reagents persisted as Washington tightened licensing.

Success drove demand and waiting lists, presented as care on European terms. Then American frontier models for clinical planning, triage and logistics were cut off abruptly without appeal, stalling patched appointment systems and forcing cancer centres back to manual scheduling.

Brussels used health emergency structures to pin clinical workloads to EU-hosted inference and middle-power allocations, throttling non-clinical loads and jointly procuring reagents — keeping wards running narrowly through compute rationing. The reserve proved the Union could sustain care and patient groups credited monitoring, but underlying external dependence remained exposed, linking remission images with paper forms and tying local compute permits to service restoration. No new builds started; Washington licensing treated as given.
```
